Literature DB >> 2709239

Effects of excipients on the crystallization of pharmaceutical compounds during lyophilization.

D J Korey, J B Schwartz.   

Abstract

Many drug compounds fail to crystallize during lyophilization, producing the less stable amorphous form. During a study to screen various excipient materials for their effect on crystallinity, the addition of certain excipients (glycine, alanine, serine, methionine, urea, and niacinamide) to aqueous solutions of atropine sulfate, cefoxitin sodium, cefotaxime sodium, cefazolin sodium, doxycycline hyclate, procainamide hydrochloride, lactose, and polyvinylpyrrolidone induced these compounds to crystallize during the freeze drying process. Crystallinity was determined by microscopic examination under polarized light. This method of producing a crystalline freeze dried solid could prove useful in the production of stable, cost-effective freeze dried pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2709239

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN: 0279-7976


  4 in total

1.  Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.

Authors:  M P te Booy; R A de Ruiter; A L de Meere
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

2.  Crystallization of cephalothin sodium during lyophilization from tert-butyl alcohol-water cosolvent system.

Authors:  Chitra Telang; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue.

Authors:  Minlu Hu; Tian Zhou; Charlene S Dezzutti; Lisa C Rohan
Journal:  AIDS Res Hum Retroviruses       Date:  2016 Oct/Nov       Impact factor: 2.205

4.  The effect of additives on the crystallization of cefazolin sodium during freeze-drying.

Authors:  Abira Pyne; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.